Status:
UNKNOWN
The Effects of Claudication Severity on Functional Outcomes
Lead Sponsor:
University of Central Lancashire
Conditions:
Intermittent Claudication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Peripheral artery disease (PAD) affects over 236 million people globally. A classic symptom of PAD is intermittent claudication (IC) which is associated with reductions in physical function. The evide...
Detailed Description
Peripheral artery disease (PAD) is a progressive disease and is characterised by atherosclerotic occlusion of the arteries in the lower limbs, resulting in a reduction of blow flow. Globally, it is es...
Eligibility Criteria
Inclusion
- \>18 years old
- Resting ankle brachial pressure index (ABPI) \<90 mmHg
- Able to walk unaided
- English speaking and able to follow exercise instructions
- Able to provide informed consent
Exclusion
- Those who have critical limb threatening ischaemia (rest pain and/or tissue loss)
- Unable to provide consent
- Those undergoing active cancer treatment
- Those presenting with any significant comorbidities or contraindications to exercise testing or training in accordance to the American College of Sports Medicine
- Unstable/uncontrolled coronary heart disease
Key Trial Info
Start Date :
July 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04370327
Start Date
July 5 2021
End Date
January 1 2025
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Sport and and Health Sciences
Preston, United Kingdom